Legal & General Group
CEMI

Legal & General Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Legal & General Group’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,180
Closed -$8K – 3794
2021
Q1 		$8K Sell
2,180
-184
-8% -$1.02K ﹤0.01% 3443
2020
Q4 		$11K Hold
2,364
– – ﹤0.01% 3331
2020
Q3 		$11K Sell
2,364
-763
-24% -$3.61K ﹤0.01% 3215
2020
Q2 		$10K Buy
+3,127
New +$29.7K ﹤0.01% 3323

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Legal & General Group's CEMI Position: Q2 2021 in Review

Legal & General Group sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 2,180 shares — an estimated $8K sold.

Legal & General Group first reported a position in CEMI in Q2 2020 and held it in 4 quarters. The position peaked at $11K in Q4 2020. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

  • Legal & General Group reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 2,180 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $8K.
  • Legal & General Group first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 4 quarters.
  • Legal & General Group's Chembio diagnostics, Inc. position peaked at $11K in Q4 2020.
  • 60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.